• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Yamamoto Masaki  山本 昌樹

ORCIDConnect your ORCID iD *help
… Alternative Names

Masaki Yamamoto  山本 昌樹

Less
Researcher Number 20597215
Other IDs
Affiliation (Current) 2026: 横浜市立大学, 附属市民総合医療センター, 准教授
Affiliation (based on the past Project Information) *help 2020 – 2022: 横浜市立大学, 附属市民総合医療センター, 講師
Review Section/Research Field
Principal Investigator
Basic Section 53030:Respiratory medicine-related
Keywords
Principal Investigator
免疫療法 / 肺がん / フェロトーシス / ヘプシジン / 非小細胞肺がん / 免疫チェックポイント阻害薬 / 非小細胞肺癌
  • Research Projects

    (1 results)
  • Research Products

    (1 results)
  •  Efficacy of immunotherapy in patients with lung cancer with increased hepcidin expressionPrincipal Investigator

    • Principal Investigator
      Masaki Yamamoto
    • Project Period (FY)
      2020 – 2022
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 53030:Respiratory medicine-related
    • Research Institution
      Yokohama City University

All 2022

All Presentation

  • [Presentation] Hepcidin expression as a predictive biomarker for anti-PD1/PDL1 antibody monotherapy for advanced non-small cell lung cancer2022

    • Author(s)
      山本昌樹
    • Organizer
      European Society for Medical Oncology Congress 2022
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20K08571

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi